A prospective randomized trial to compare efficacy of topical loteprednol etabonate 0.5% versus cyclosporine-a 0.05% for treatment of dry eye syndrome following hematopoietic stem cell transplantation

Trial Profile

A prospective randomized trial to compare efficacy of topical loteprednol etabonate 0.5% versus cyclosporine-a 0.05% for treatment of dry eye syndrome following hematopoietic stem cell transplantation

Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Feb 2016

At a glance

  • Drugs Loteprednol etabonate (Primary) ; Ciclosporin
  • Indications Dry eyes
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 Feb 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top